Do antiestrogens and antiprogestins act as hormone antagonists or receptor-targeted drugs in breast cancer?
- 30 April 1987
- journal article
- editorial
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 8 (4), 126-128
- https://doi.org/10.1016/0165-6147(87)90180-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antiestrogen action in breast cancer cells: Modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sitesBreast Cancer Research and Treatment, 1985
- The Antiprogestin RU38 486: Receptor-Mediated ProgestinVersusAntiprogestin Actions Screened in Estrogen-Insensitive T47DCOHuman Breast Cancer Cells*Endocrinology, 1985
- RU486, A Progestin and Glucocorticoid Antagonist, Inhibits the Growth of Breast Cancer Cells via the Progesterone Receptor*Journal of Clinical Endocrinology & Metabolism, 1985
- Differential Effects of Tamoxifen and Analogs with Nonbasic Side Chains on Cell Proliferationin VitroEndocrinology, 1985
- A 250-kilodalton cellular protein is induced by progestins in two human breast cancer cell lines MCF7 and T47DBiochemical and Biophysical Research Communications, 1984
- Steroidal and non steroidal antiestrogens in breast cancer cells in cultureJournal of Steroid Biochemistry, 1984
- Adjuvant systemic therapy in breast cancer; a reviewEuropean Journal of Cancer and Clinical Oncology, 1983
- Antiestrogenic Effect of R5020, a Synthetic Progestin in Human Breast Cancer Cells in Culture*Journal of Clinical Endocrinology & Metabolism, 1983
- High-affinity anti-oestrogen binding site distinct from the oestrogen receptorNature, 1980
- The Use of Estrogen Antagonists in Hormone Receptor StudiesGynecologic and Obstetric Investigation, 1972